Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 229-233

  Simpson, Andrea N ^a   Feigenberg, Tomer ^a,e   Clarke, Blaise A ^b   Gien, Lilian T ^c   Ismiil, Nadia ^c   Laframboise, Stephane ^a   Massey, Christine ^d   Ferguson, Sarah E ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d Independent Biostatistician   (Canada)

^e CREDIT VALLEY HOSPITAL   (Canada)

Author keywords

Conservative treatment; Endometrial atypical hyperplasia; Endometrial cancer; Fertility sparing; Progestin therapy

Indexed keywords

CLOMIFENE; GESTAGEN;

ADULT; ARTICLE; CANCER CENTER; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MEGADOSE; ENDOMETRIOID ADENOCARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INTRAUTERINE INSEMINATION; LIVE BIRTH; LOW DRUG DOSE; LYMPH NODE DISSECTION; OMENTECTOMY; OUTCOME ASSESSMENT; OVARY CANCER; PREGNANCY OUTCOME; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; SALPINGOOOPHORECTOMY; SALVAGE THERAPY; SPONTANEOUS ABORTION; TREATMENT DURATION; TREATMENT RESPONSE;

CONSERVATIVE TREATMENT; ENDOMETRIAL ATYPICAL HYPERPLASIA; ENDOMETRIAL CANCER; FERTILITY SPARING; PROGESTIN THERAPY;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY PRESERVATION; HUMANS; HYSTERECTOMY; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NEOPLASM GRADING; ORGAN SPARING TREATMENTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84899627169     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.020     Document Type: Article

References (36)

1. H. Lajer, S. Elnegaard, R.D. Christensen, G. Ortoft, D.E. Schledermann, and O. Mogensen Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey Acta Obstet Gynecol Scand 91 8 2012 976 982
2. P.T. Soliman, J.C. Oh, K.M. Schmeler, C.C. Sun, B.M. Slomovitz, and D.M. Gershenson et al. Risk factors for young premenopausal women with endometrial cancer Obstet Gynecol 105 3 2005 575 580
3. S. Papaioannou, and J. Tzafettas Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer Best Pract Res Clin Obstet Gynaecol 24 1 2010 19 27
4. P.T. Soliman, D. Wu, G. Tortolero-Luna, K.M. Schmeler, B.M. Slomovitz, and M.S. Bray et al. Association between adiponectin, insulin resistance, and endometrial cancer Cancer 106 11 2006 2376 2381
5. J. Dorais, M. Dodson, J. Calvert, B. Mize, J.M. Travarelli, and K. Jasperson et al. Fertility-sparing management of endometrial adenocarcinoma Obstet Gynecol Surv 66 7 2011 443 451
6. M. Yasuda, N. Matsui, H. Kajiwara, R.Y. Osamura, T. Miyamoto, and M. Murakami et al. Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation Pathol Int 54 6 2004 451 456
7. G. Ferrandina, G.F. Zannoni, V. Gallotta, E. Foti, S. Mancuso, and G. Scambia Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report Gynecol Oncol 99 1 2005 215 217
8. T. Ota, M. Yoshida, M. Kimura, and K. Kinoshita Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger Int J Gynecol Cancer 15 4 2005 657 662
9. G. Cormio, R. Martino, V. Loizzi, L. Resta, and L. Selvaggi A rare case of choroidal metastasis presented after conservative management of endometrial cancer Int J Gynecol Cancer 16 6 2006 2044 2048
10. K. Ushijima, H. Yahata, H. Yoshikawa, I. Konishi, T. Yasugi, and T. Saito et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women J Clin Oncol 25 19 2007 2798 2803
11. S.S. Lentz, M.F. Brady, F.J. Major, G.C. Reid, and J.T. Soper High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 14 2 1996 357 361
12. T. Kaku, H. Yoshikawa, H. Tsuda, A. Sakamoto, M. Fukunaga, and Y. Kuwabara et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome Cancer Lett 167 1 2001 39 48
13. A. Gadducci, N. Spirito, E. Baroni, R. Tana, and A.R. Genazzani The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option Gynecol Endocrinol 25 10 2009 683 691
14. K.R. Penner, O. Dorigo, C. Aoyama, N. Ostrzega, B.L. Balzer, and J. Rao et al. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy Gynecol Oncol 124 3 2012 542 548
15. J.Y. Park, S.H. Lee, S.J. Seong, D.Y. Kim, T.J. Kim, and J.W. Kim et al. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin Gynecol Oncol 129 1 2013 7 11
16. E.J. Robbe, S.M. van Kuijk, E.M. de Boed, L.J. Smits, A.A. van der Wurff, and R.F. Kruitwagen et al. Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples Int J Gynecol Cancer 22 7 2012 1264 1272
17. C.L. Trimble, J. Kauderer, R. Zaino, S. Silverberg, P.C. Lim, and J.J. Burke II et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study Cancer 106 4 2006 812 819
18. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, K.R. Kim, and Y.T. Kim et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002) Eur J Cancer 49 4 2013 868 874
19. Z. Eftekhar, N. Izadi-Mood, F. Yarandi, H. Shojaei, Z. Rezaei, and S. Mohagheghi Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients Int J Gynecol Cancer 19 2 2009 249 252
20. A.R. Han, Y.S. Kwon, D.Y. Kim, J.H. Kim, Y.M. Kim, and Y.T. Kim et al. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia Int J Gynecol Cancer 19 1 2009 147 151
21. K. Yamazawa, M. Hirai, A. Fujito, H. Nishi, F. Terauchi, and H. Ishikura et al. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer Hum Reprod 22 7 2007 1953 1958
22. K. Garg, K. Shih, R. Barakat, Q. Zhou, A. Iasonos, and R.A. Soslow Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset Am J Surg Pathol 33 12 2009 1869 1877
23. A. Orbo, M.N. Nilsen, M.S. Arnes, I. Pettersen, and K. Larsen Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia Int J Gynecol Pathol 22 2 2003 141 148
24. D.T. Wheeler, R.E. Bristow, and R.J. Kurman Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins Am J Surg Pathol 31 7 2007 988 998
25. I.D. Gallos, J. Yap, M. Rajkhowa, D.M. Luesley, A. Coomarasamy, and J.K. Gupta Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis Am J Obstet Gynecol 207 4 2012 266 [e1-12]
26. S. Erkanli, and A. Ayhan Fertility-sparing therapy in young women with endometrial cancer: 2010 update Int J Gynecol Cancer 20 7 2010 1170 1187
27. C.C. Gunderson, A.N. Fader, K.A. Carson, and R.E. Bristow Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review Gynecol Oncol 125 2 2012 477 482
28. L. Chiva, F. Lapuente, L. Gonzalez-Cortijo, N. Carballo, J.F. Garcia, and A. Rojo et al. Sparing fertility in young patients with endometrial cancer Gynecol Oncol 111 2 Suppl. 2008 S101 S104
29. H.S. Hahn, S.G. Yoon, J.S. Hong, S.R. Hong, S.J. Park, and J.Y. Lim et al. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer Int J Gynecol Cancer 19 6 2009 1068 1073
30. W.H. Gotlieb Fertility preserving treatments for endometrial cancer: the unanswered questions Gynecol Oncol 129 1 2013 1 2
31. W.H. Parker, D. Feskanich, M.S. Broder, E. Chang, D. Shoupe, and C.M. Farquhar et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study Obstet Gynecol 121 4 2013 709 716
32. G. Gitsch, E. Hanzal, D. Jensen, and N.F. Hacker Endometrial cancer in premenopausal women 45 years and younger Obstet Gynecol 85 4 1995 504 508
33. V. Bonadona, B. Bonaiti, S. Olschwang, S. Grandjouan, L. Huiart, and M. Longy et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome JAMA 305 22 2011 2304 2310
34. L. Baglietto, N.M. Lindor, J.G. Dowty, D.M. White, A. Wagner, and E.B. Gomez Garcia et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers J Natl Cancer Inst 102 3 2010 193 201
35. P. Dursun, S. Erkanli, A.B. Guzel, M. Gultekin, N.C. Tarhan, and O. Altundag et al. A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer Int J Gynaecol Obstet 119 3 2012 270 273
36. R. Kudesia, T. Singer, T.A. Caputo, K.M. Holcomb, I. Kligman, Z. Rosenwaks, and D. Gupta et al. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma Am J Obstet Gynecol. 210 3 2014 255.e1 255.e4